Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system

Acta Neuropathologica

Volumn 96, Issue 2, 1998, Pages 157-162

  Deckert Schlüter, Martina ^a   Rang, Andrea ^a   Wiestler, Otmar D ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Apoptosis; B cell; Bcl 2; Central nervous system; Lymphoma

Indexed keywords

PROTEIN BAX; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; APOPTOSIS; BRAIN; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; GENES, BCL-1; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROTEINS;

EID: 0031817914     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050876     Document Type: Article

References (44)

1. y and bcl-2 protein in non-Hodgkin's lymphomas. Pathol Int 45: 422-429
2. Baiocchi RA, Khatri VP, Lindemann MJ, Ross ME, Papoff G, Caprio AJ, Caprio TV, Fenstermaker R, Ruberti G, Bernstein ZP, Caligiuri MA (1997) Phenotypic and functional analysis of Fas (CD95) expression in primary central nervous system lymphomas of patients with acquired immunodeficiency syndrome. Blood 90: 1737-174
3. Bergmann M, Blasius S, Bankfalvi A, Mellin W (1996) Primary non-Hodgkin lymphomas of the CNS - proliferation, oncoproteins and Epstein-Barr-virus. Gen Diagn Pathol 141: 235-242
4. Camilleri-Broet S, Davi F, Feuillard J, Bourgois C, Seilhean D, Hauw JJ, Raphael M (1995) High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas. Blood 86: 432-435
5. Camilleri-Broet S, Davi S, Feuillard J, Seilhean D, Michiels JF, Brousset P, Epardeau B, Navratil E, Mokhtari K, Bourgeois C, Marelle L, Raphael M, Hauw JJ (1997) AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-Associated Tumors. Hum Pathol 28: 367-374
6. Cherney BW, Bhatia KG, Sgadari C, Gutierrez MI, Mostowski H, Pike SE, Gupta G, Magrath IT, Tosato G (1997) Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells. Cancer Res 57: 2508-2515
7. Cobbers JMJL, Wolter M, Reifenberger J, Ring GU, Jessen F, An H, Niederacher D, Schmidt EE, Ichimura K, Floeth F, Kirsch L, Borchard F, Louis DN, Collins P, Reifenberger G (1998) Frequent inactivation of CDKN2A and rare mutation of TP53 in primary central nervous system non-Hodgkin's lymphomas from immunocompetent patients. Brain Pathol (in press)
8. Cory S (1995) Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 13: 513-543
9. Evans-Storms RB, Cidlowksi JA (1995) Regulation of apoptosis by steroid hormones. J Steroid Biochem Mol Biol 53: 1-8
10. Gascoyne RD, Adomat SA, Krajewski S, Krajewska M, Horsman DE, Tolcher AW, O'Reilly SE, Hoskins P, Coldman AJ, Reed JC, Connors JM (1997) Prognostic significance of bcl-2 protein expression and bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 90: 244-251
11. Gaulard P, d'Aeay MF, Peuchmaur M, Brousse N, Gissel-brecht C, Solal-Celigny P, Diebold J, Mason DY (1992) Expression of the bcl-2 gene product in follicular lymphoma. Am J Pathol 140: 1089-1095
12. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501
13. Gelb AB, Rouse RV, Dorfman RF, Warnke RA (1994) Detection of immunophenotypic abnormalities in paraffin-embedded B-lineaae Non-Hodgkin's lymphomas. Am J Clin Pathol 102: 825-834
14. Harris AL (1990) Mutant p53 - the commonest genetic abnormality in human cancer? J Clin Pathol 162: 5-6
15. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer, Warnke R (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84: 1361-1392
16. Hockenberry D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336
17. Ichikawa A, Kinoshita T, Watanabe T, Kato H, Nagai H, Tsushita K, Saito H, Hotta T (1997) Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med 337: 529-534
18. Iwata M (1995) Regulation of apoptosis via steroid receptors. Curr Top Microbiol Immunol 200: 81-94
19. Jellinger KA, Paulus W (1992) Primary central nervous system lymphomas - an update. J Cancer Res Clin Oncol 119: 7-27
20. Jellinger KA, Paulus W (1995) Primary central nervous system lymphomas - new pathological developments. J Neurooncol 24: 33-36
21. Korsmeyer SJ (1992) Bcl-2: a repressor of lymphocyte death. Immunol Today 13: 285-288
22. Krajewski S, Krajewska M, Ehrmann J, Sikorska M, Lach B, Chatten J, Reed JC (1997) Immunohistochemical analysis of Bcl-2, Bcl-x, Mcl-1, and Bax in tumors of central and peripheral nervous system origin. Am J Pathol 150: 805-814
23. Meijerink JP, Smetsers TF, Sloetjes AW, Linders EH, Mensink EJ (1995) Bax mutations in cell lines derived from hematological malignancies. Leukemia 9: 1828-1832
24. Migheli A, Cavalla P, Marino S, Schiffer D (1994) A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol 53: 606-616
25. Montserrat E (1997) Chronic lymphoproliferative disorders. Curr Opin Oncol 9: 34-41
26. Nguyen PL, Harris NL, Ritz J, Robertson MJ (1996) Expression of CD95 antigen and bcl-2 protein in Non-Hodgkin's lymphomas and Hodgkin's disease. Am J Pathol 148: 847-853
27. Ohta K, Iwai K, Kasahara Y, Taniguchi N, Krajewski, S, Reed JC, Miyawaki T (1995) Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues, Int Immunol 7: 1817-1825
28. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY (1990) Expression of the bcl-2 oncogene protein is not specific for the 14;18 translocation. Am J Pathol 137: 225-232
29. Raff MC (1992) Social controls on cell survival and cell death. Nature 356: 397-400
30. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD (1993) Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262: 695-700
31. Reifenberger J, Ring GU, Gies U, Cobbers L, Oberstrass J, An HX, Niederacher D, Wechsler W, Reifenberger G (1996) Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 55: 822-831
32. Robertson LE, Plunkett W, McConnell K, Keating MJ, McDonnell TJ (1996) Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia 10: 456-459
33. Sangfell O, Einhorn S, Bjorklund AC, Wiman KG, Okan I, Grander D (1996) Wild-type p53-induced apoptosis in a Burkitt lymphoma cell line is inhibited by interferon gamma. Int J Cancer 67: 106-112
34. Sattler M, Liang N, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ, Thompson CB, Fesik SW (1997) Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275: 983-986
35. Swerdlow SH, Utz GL, Williams ME (1993) Bcl-2 oncoprotein in cenirocytic lymphomas: a paraffin section study. Leukemia 7: 1456-1458
36. Symmans WF, Katz RL, Ordonez NG, Dulton H, Romaguera JE, Cabanillas F (1995) Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation. Acta Cytol 39: 673-682
37. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM (1994) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation, Science 226: 1097-1099
38. Wang T, Lasota J, Hanau CA, Miettinen M (1995) Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value. APMIS 103: 655-662
39. Werner MH, Phuphanich S, Lyman GH (1995) The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer 76: 1634-1642
40. Vaux DL (1993) Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 90: 786-789
41. Williams GT, Smith CA (1993) Molecular regulation of apoptosis: genetic controls on cell death. Cell 74: 777-779
42. Wyllie AH (1987) Apoptosis: cell death in tissue regulation. J Pathol 153: 313-316
43. Wynford-Thomas D (1996) P53: guardian of cellular senescence. J Pathol 180: 118-121
44. Yin XM, Oltvai ZN, Korsmeyer SJ (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321-323